The list of over 100 potential mRNA vaccine manufacturers follows a list of 10 potential mRNA manufacturers published by the
New York Times. Indian civil society organizations have
identified a list of potential manufacturers to scale up the production of the J&J vaccine.
“There are over 100 companies across Africa, Asia, and Latin America who have the capacity to make an mRNA vaccine,” said Achal Prabhala from the AccessIBSA project. “These companies can bridge the yawning inequity in mRNA vaccine supply in poor countries. All they need is for the US and German governments to end monopolies and share the valuable technology they funded and essentially created with them.”
Potential manufacturers need access to intellectual property, vaccine technology, and materials to produce more vaccines for a swifter and more equitable Covid-19 response. India and South Africa’s
proposal to temporarily waive some global intellectual property and trade rules remains stalled at the World Trade Organization.
A waiver would enable governments to collaborate on expanding the manufacture of Covid-19 vaccines, treatments, and testing without fearing trade-based retaliation. Over 60 low- and middle-income governments are co-sponsoring the proposal. The US government has
signaled support for a waiver. High-income governments, including Germany and the
European Commission, are among those who have consistently blocked the waiver.
These governments should drop their opposition to the TRIPS waiver immediately and work toward swift adoption, Human Rights Watch said.